New Anti-Inflammatory Treatment Extends Lifespan in Mice by 25%

Researchers find that inhibiting the IL-11 protein in mice leads to longer, healthier lives, reducing cancer and age-related diseases.

Mice treated with anti-IL-11 antibodies lived 25% longer and showed fewer signs of aging.
The treatment reduced cancer incidence and improved muscle strength and metabolism in mice.
IL-11 is linked to chronic inflammation and multimorbidity, conditions prevalent in aging.
Current clinical trials are exploring the safety and effectiveness of anti-IL-11 treatments in humans.
Researchers emphasize the need for long-term human studies to confirm these findings.